Duality Biotherapeutics, Inc. (HKG:9606)

Duality Biotherapeutics Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023
Period Ending	Sep 29, 2025	Dec 31, 2024	Dec 31, 2023
Debt / Equity Ratio	0.02	0.00	0.00
Debt / EBITDA Ratio	-	-	0.01
Debt / FCF Ratio	0.10	0.02	0.01
Asset Turnover	-	1.08	-
Quick Ratio	4.64	0.48	0.50
Current Ratio	4.73	0.49	0.52
Return on Assets (ROA)	-	-6.51%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.